Skip to main content

Table 2 Prevalence of multidrug-resistant gram-negative organisms in males tested positive for HIV and males tested negative for HIV

From: Elevated prevalence of multidrug-resistant gram-negative organisms in HIV positive men

 

HP

HN

Number of patients (n)

109

109

Median age and standard deviation (years)

46; 10.8

46; 11.0

Tested positive for MDRGN

(%; 95% CI; n)

23.9; 16.2–32.9; 26

8.3; 3.8–15.1; 9

Total number of MDRGN isolates (n)

35

Thereof (n)

26

9

E. coli ESBL/FQ (%; 95%CI; n)

73.1; 52.2–88.4; 19

66.7; 29.9–92.5; 6

E. coli ESBL (%; 95%CI; n)

23.1; 8.9–43.6; 6

11.1; 0.3–48.3; 1

K. pneumoniae ESBL/FQ (%; 95%CI; n)

3.8; 0.0–19.6; 1

22.2; 2.8–60.0; 2

MDRGN with resistance to carbapenems

0

0

  1. Abbreviations: HIV human immunodeficiency virus; HP males tested positive for infection with HIV; HN males tested negative for infection with HIV; MDRGN multidrug-resistant gram-negative organism. E. coli ESBL: resistant due to ESBL expression; E. coli/K. pneumoniae ESBL/FQ: ESBL and resistance to fluoroquinolones